Adoptive transfer of tumor-infiltrating lymphocytes for melanoma: new players, old game

被引:0
作者
Ben-Ami, Eytan [1 ]
Schachter, Jacob [1 ]
机构
[1] Chaim Sheba Med Ctr, Div Oncol, Ella Lemelbaum Inst Melanoma, IL-52621 Tel Hashomer, Israel
关键词
adoptive cell transfer; immunotherapy; melanoma; tumor-infiltrating lymphocytes; METASTATIC MELANOMA; CANCER-IMMUNOTHERAPY; THERAPY; IPILIMUMAB; NIVOLUMAB;
D O I
10.2217/IMT.15.20
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
引用
收藏
页码:477 / 479
页数:3
相关论文
共 18 条
  • [1] High-dose recombinant interleukin 2 therapy for patients with metastatic melanoma: Analysis of 270 patients treated between 1985 and 1993
    Atkins, MB
    Lotze, MT
    Dutcher, JP
    Fisher, RI
    Weiss, G
    Margolin, K
    Abrams, J
    Sznol, M
    Parkinson, D
    Hawkins, M
    Paradise, C
    Kunkel, L
    Rosenberg, SA
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 1999, 17 (07) : 2105 - 2116
  • [2] Is there a future for adoptive cell transfer in melanoma patients?
    Besser, Michal J.
    [J]. ONCOIMMUNOLOGY, 2013, 2 (10)
  • [3] Adoptive Transfer of Tumor-Infiltrating Lymphocytes in Patients with Metastatic Melanoma: Intent-to-Treat Analysis and Efficacy after Failure to Prior Immunotherapies
    Besser, Michal J.
    Shapira-Frommer, Ronnie
    Itzhaki, Orit
    Treves, Avraham J.
    Zippel, Douglas B.
    Levy, Daphna
    Kubi, Adva
    Shoshani, Noa
    Zikich, Dragoslav
    Ohayon, Yaara
    Ohayon, Daniel
    Shalmon, Bruria
    Markel, Gal
    Yerushalmi, Ronit
    Apter, Sara
    Ben-Nun, Alon
    Ben-Ami, Eytan
    Shimoni, Avichai
    Nagler, Arnon
    Schachter, Jacob
    [J]. CLINICAL CANCER RESEARCH, 2013, 19 (17) : 4792 - 4800
  • [4] Cancer Immunotherapy
    Couzin-Frankel, Jennifer
    [J]. SCIENCE, 2013, 342 (6165) : 1432 - 1433
  • [5] Improved Survival with Ipilimumab in Patients with Metastatic Melanoma
    Hodi, F. Stephen
    O'Day, Steven J.
    McDermott, David F.
    Weber, Robert W.
    Sosman, Jeffrey A.
    Haanen, John B.
    Gonzalez, Rene
    Robert, Caroline
    Schadendorf, Dirk
    Hassel, Jessica C.
    Akerley, Wallace
    van den Eertwegh, Alfons J. M.
    Lutzky, Jose
    Lorigan, Paul
    Vaubel, Julia M.
    Linette, Gerald P.
    Hogg, David
    Ottensmeier, Christian H.
    Lebbe, Celeste
    Peschel, Christian
    Quirt, Ian
    Clark, Joseph I.
    Wolchok, Jedd D.
    Weber, Jeffrey S.
    Tian, Jason
    Yellin, Michael J.
    Nichol, Geoffrey M.
    Hoos, Axel
    Urba, Walter J.
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2010, 363 (08) : 711 - 723
  • [6] Huan S, 2014, MOL CANCER, V13, P219
  • [7] Gene therapy with human and mouse T-cell receptors mediates cancer regression and targets normal tissues expressing cognate antigen
    Johnson, Laura A.
    Morgan, Richard A.
    Dudley, Mark E.
    Cassard, Lydie
    Yang, James C.
    Hughes, Marybeth S.
    Kammula, Udai S.
    Royal, Richard E.
    Sherry, Richard M.
    Wunderlich, John R.
    Lee, Chyi-Chia R.
    Restifo, Nicholas P.
    Schwarz, Susan L.
    Cogdill, Alexandria P.
    Bishop, Rachel J.
    Kim, Hung
    Brewer, Carmen C.
    Rudy, Susan F.
    VanWaes, Carter
    Davis, Jeremy L.
    Mathur, Aarti
    Ripley, Robert T.
    Nathan, Debbie A.
    Laurencot, Carolyn M.
    Rosenberg, Steven A.
    [J]. BLOOD, 2009, 114 (03) : 535 - 546
  • [8] The blockade of immune checkpoints in cancer immunotherapy
    Pardoll, Drew M.
    [J]. NATURE REVIEWS CANCER, 2012, 12 (04) : 252 - 264
  • [9] Nivolumab in Previously Untreated Melanoma without BRAF Mutation
    Robert, Caroline
    Long, Georgina V.
    Brady, Benjamin
    Dutriaux, Caroline
    Maio, Michele
    Mortier, Laurent
    Hassel, Jessica C.
    Rutkowski, Piotr
    McNeil, Catriona
    Kalinka-Warzocha, Ewa
    Savage, Kerry J.
    Hernberg, Micaela M.
    Lebbe, Celeste
    Charles, Julie
    Mihalcioiu, Catalin
    Chiarion-Sileni, Vanna
    Mauch, Cornelia
    Cognetti, Francesco
    Arance, Ana
    Schmidt, Henrik
    Schadendorf, Dirk
    Gogas, Helen
    Lundgren-Eriksson, Lotta
    Horak, Christine
    Sharkey, Brian
    Waxman, Ian M.
    Atkinson, Victoria
    Ascierto, Paolo A.
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2015, 372 (04) : 320 - 330
  • [10] Anti-programmed-death-receptor-1 treatment with pembrolizumab in ipilimumab-refractory advanced melanoma: a randomised dose-comparison cohort of a phase 1 trial
    Robert, Caroline
    Ribas, Antoni
    Wolchok, Jedd D.
    Hodi, F. Stephen
    Hamid, Omid
    Kefford, Richard
    Weber, Jeffrey S.
    Joshua, Anthony M.
    Hwu, Wen-Jen
    Gangadhar, Tara C.
    Patnaik, Amita
    Dronca, Roxana
    Zarour, Hassane
    Joseph, Richard W.
    Boasberg, Peter
    Chmielowski, Bartosz
    Mateus, Christine
    Postow, Michael A.
    Gergich, Kevin
    Elassaiss-Schaap, Jeroen
    Li, Xiaoyun Nicole
    Iannone, Robert
    Ebbinghaus, Scot W.
    Kang, S. Peter
    Daud, Adil
    [J]. LANCET, 2014, 384 (9948) : 1109 - 1117